A fluoroacetate-resistant mutant of Escherichia coli K-12 (MM-294) accumulated less acetate in the medium during growth to high cell density in fermentor cultures and was shown to be defective in its phosphotransacetylase activity. The mutant had an improved ability to continue growing during induction of interleukin-2 (IL-2) synthesis, and in fermentor cultures it gave a higher level of specific IL-2 accumulation than its parent during expression under control of the temperature-sensitive PL promoter. In flask cultures at lower cell density, the mutant again produced less acetate than the parent, although both showed a much lower level of acetate accumulation than that seen in fermentors at high cell density. Both showed a higher specific expression level of IL-2 in flask cultures, and there was a greater difference between the mutant and its parent in the final extent of specific IL-2 accumulation in fermentor cultures compared with flask cultures. Thus, the concentration of acetate in the medium, which was much higher in fermentor cultures (.300 mM after 5 h of induction) than in flask cultures ('3 mM) of the parent organism, was a significant factor in limiting expression of the heterologous protein product, IL-2. The acetate kinase-phosphotransacetylase pathway was therefore a major source of acetate formation in these cultures. Blocking this pathway improved accumulation of IL-2 and did not slow growth.
Organic acids accumulate in the culture medium during aerobic growth of Escherichia coli on glucose (17) . The most abundant organic acid is often acetic, and its concentration can build up to levels that are inhibitory to growth (1, 13) . In a previous study (10) , we showed that intracellular accumulation of interleukin-2 (IL-2), under control of the temperature-sensitive bacteriophage lambda PL promoter, was inversely correlated with cell density and acetate accumulation in fermentor cultures. These observations provided circumstantial evidence that acetate was at least partially responsible for the cessation of product accumulation during expression of heterologous genes in E. coli and suggested that higher levels of IL-2 accumulation could be expected if acetate formation could be blocked.
Two enzymatic pathways for acetate formation in E. coli have been identified. Acetate can be derived directly from pyruvate by pyruvate oxidase, but the activity of this enzyme in E. coli is thought to be too low to account for the amount of acetate produced (4) . Acetate can also be derived from acetylcoenzyme A (CoA) by the acetate kinase-phosphotransacetylase (ACK-PTA) pathway (3) . In E. coli B, PTA is activated by pyruvate and inhibited by NADH (14) . The genes coding for PTA and ACK have been mapped and form an operon in E. coli and Salmonella typhimurium which is induced as much as twofold under anaerobic conditions (8) . Mutants defective in both activities can be isolated by selection for fluoroacetate resistance (3) .
In the work presented here, we examined the role of the ACK-PTA pathway in the formation of acetate during intracellular accumulation of IL-2. We isolated 52 fluoroacetateresistant mutants from E. coli MM294-1 and partially char-* Corresponding author.
acterized them. Some of these mutants had reduced acetateforming ability, as low as 10 to 20% of parental levels in flask cultures, with near-normal aerobic growth rates on glucose. We describe here the characterization of one of these mutants and its performance as a host strain for PL promoter-driven accumulation of IL-2.
MATERIALS AND METHODS
Strains. All strains used in this study were derived from E. coli K-12 and are listed in Table 1 . Phage stocks used for testing c1857 function were the gift of D. Gelfand. HW21 was the gift of H. C. Wong. The poxB strains were the gift of J. E. Cronan and the pta-ack deletion strains were the gift of G. F.-L. Ames.
Media. N8-2 medium consisted of NH4Cl (10 mM), KH2PO4 (21.9 mM), Na2HPO4 (28.1 mM), K2SO4 (9 mM), MgSO4 (0.2 mM), MnSO4 (3 ,M), ZnSO4 (3 ,uM) , and CuSO4 (0.1 ,uM) in deionized water. The medium was sterilized by autoclaving, after which the following sterile additions were made: glucose (2 g/liter); thiamine hydrochloride (10 mg/liter); FeSO4 (10 ,uM) .
Minimal agar plates were of similar composition to defined flask medium (see below), except that the trace metals solution was 1 ml/liter, MgSO4 was at 1 mM, and agar was added to 1.5% (wt/vol). Alternate carbon sources (galactose or sodium pyruvate) were also used at 5 g/liter. Ampicillin (50 mg/liter) and tetracycline (15 mg/liter) were used as indicated. Sodium monofluoroacetate (Tull Chemical Co., Inc., Oxford, Ala.) was added to 25 mM as indicated.
R2-4 agar plates were standard rich-medium plates described elsewhere (10) .
Isolation plates were composed of Na2HPO4 (5.68 g/liter), KH2PO4 (3.54 g/liter), trisodium citrate. 2H20 (0.44 g/liter), a solution containing ZnSO4 (30 mM), MnSO4 (30 mM), and Defined flask medium consisted of trisodium citrate (4 mM), (NH4)2SO4 (10 mM), KH2PO4 (50 mM), and trace metals solution (2) (4 ml/liter). The pH of the medium was adjusted to 6.8 with NaOH, and the solution was autoclaved. Glucose (5 g/liter), thiamine hydrochloride (20 mg/liter), and MgSO4 (3 mM) were added to the cooled medium from sterile concentrated stock solutions.
For fermentor medium, the medium of Bauer and Shiloach (2) with some modifications was used as described previously (10) , except that 20 mg of thiamine hydrochloride per liter was added after autoclaving. The 14-liter Chemap fermentors as well as inoculation and operating conditions used in this study were as described previously (10) .
Assays. Assays for acetate, cell growth, and IL-2 in isolated refractile bodies, as well as the various conversion factors used, were as described previously (10) .
(i) Preparation of cell extracts. Cell extracts for assays of PTA and ACK activities were prepared as follows: 100 ml of a defined flask medium culture in exponential growth was centrifuged at 3,000 x g for 10 min at 5°C and then washed twice in 30 ml of 10 mM sodium phosphate buffer, pH 7.5 (at room temperature), which included 10 mM MgCl2 and 1 For both enzyme assays, the reactions were started by addition of extract and followed by measuring the change in A340 over time at room temperature, using a HewlettPackard HP8452A spectrophotometer equipped with enzyme kinetics software. PTA activity was shown to be completely dependent on the presence of both primary substrates, acetylphosphate and CoA. ACK activity was dependent on the presence of ATP and was greatly reduced but not eliminated when acetate was omitted. This was probably due to the presence of other ATPases in the crude extracts. Boiling the extracts eliminated all activity in both assays. Both assays were used in the linear range of enzyme activity.
Genetic techniques. (i) Selection of low-acetate-producing strains. The ACK-PTA pathway is bi-directional and allows entry of acetate into central metabolism via acetyl-CoA. Mutants with low acetate-producing ability were therefore selected by isolating strains resistant to the tricarboxylic acid cycle inhibitor fluoroacetate (3, 9) . E. coli MM294-1 was grown in nutrient broth to a cell density of approximately 2.0 OD680 (approximately 3 x 109 cells per ml). Cells were then plated at approximately 2 x 107, 2 x 108, and 2 x 109 cells per plate on isolation plates containing either lactate plus fluoroacetate or pyruvate plus fluoroacetate and incubated at 37°C for 3 days. A total of 52 individual colonies were picked from these plates, streaked for isolation onto the same selective medium, and incubated at 37°C. Because there was still perceptible growth of carry-over wild-type cells on some plates, the 52 isolates were again picked from single colonies, streaked for a second time onto fresh plates containing the same selective medium, and incubated at 37°C. Single colonies were again picked after 48 h, suspended in 1 ml of saline, and streaked for a third time onto fresh selective medium. The same isolates were also streaked onto medium containing acetate as sole carbon source to test for differences in ability to grow on acetate.
Strains were evaluated for acetate production and growth rate by inoculating 125-ml flasks containing 25 ml of prewarmed N8-2 medium at an initial cell density of 0.05 OD680.
Cultures were incubated at 37°C on a New Brunswick rotary VOL. 56, 1990 shaker at 200 rpm, and density readings were taken approximately every 0.5 h. At approximately 1.2 OD680, small culture samples were taken for acetate analysis. Many of the 52 isolates showed greatly reduced acetate accumulation, some as little as 10% of parental levels. Strain MD050 were selected for further experimentation because it consistently gave the lowest levels of acetate accumulation and had a growth rate essentially indistinguishable from that of its parent (approximately 0.6 h-').
(ii) P1 transduction. Genetic elements coding for markers such as c1857, Thi+, and poxB::Tn5 were transferred by P1 transduction, essentially as described by Miller (12) . To select for c1857, recipient strains were first made Gal-, using a lysate grown on MM294:galE::TnJO. This intermediate was then transduced back to Gal' by using a lysate grown on DG116 (a strain containing cI857 in the chromosome). Colonies were screened for cotransduction of the tightly linked c1857 marker by testing for lambda resistance at 30 and 41°C. To select for the Thi+ phenotype, strains were plated on minimal glucose agar plates without thiamine. The resulting colonies were restreaked for purity and then grown in glucose-containing defined flask medium lacking thiamine to confirm that their growth rate in this medium was identical to that of the parent strain in thiamine-containing medium.
(iii) poxB-containing strains. To create a Pta-poxB double mutant, the poxB::Tn5 mutation from MH6 was transduced into KB100. To confirm that the poxB mutation had been transferred, a lysate was grown on the putative double mutant and used to transduce YYC201 to kanamycin resistance. The resulting transductants were shown to be poxB on pyruvate tetrazolium plates, as described by Chang and Cronan (5). RESULTS Characterization of MD050. (i) PTA activity. Selection for fluoroacetate resistance results in mutations in at least two genes, pta and ack (3, 9) . MD050 was a presumptive Ptamutant based on its reduced acetate secretion levels and slow growth rate on acetate-containing plates. To confirm this, PTA and ACK activities were compared in MDO5OL(pFC54.t) and HW21(pFC54.t) grown at 30°C in defined medium. The two host strains were isogenic, except for the lesion recovered by fluoroacetate selection; they were both derived from the same MM294-1 parent. The only other difference between them was that HW21 was Thi+, allowing it to grow without the addition of thiamine to the medium. This change made no discernible difference to either acetate formation or IL-2 expression in HW21 when compared with its parent MM294-1 (data not shown). All defined media used here included thiamine.
Three sets of extracts were prepared on separate days from shake flask cultures grown at 30°C (i.e., repressed IL-2 expression). The results ( Table 2 ) clearly showed that MDOOL had greatly reduced PTA activity. No PTA activity was detected in the mutant in the first set of assays (detection limit, <1% of wild type), and small amounts (1.5% or less of wild type) were detected in the subsequent two tests. The low PTA activity in the second extract of MDO5OL ( Table 2 . Further sonication resulted in a small increase in the PTA activity seen in HW21 extracts, but the minute amount of activity seen in MDOOL extracts was lost altogether. The observed enzyme activity differences were therefore not due to differences in the extent of cell breakage between the two strains, and the small amount of apparent PTA activity in MDOSOL was probably due to an activity other than normal PTA. ACK activity in the mutant strain was higher than that in the PTA-competent strain by 2.7-fold in the first assay, 1.5-fold in the second, and 1.3-fold in the third assay. Enhanced ACK activity in pta mutants has not been reported in the literature; in fact, in one report, mutations in pta were said to have no effect on ACK activity (3).
(ii) Acetate accumulation. To determine the extent of acetate accumulation in flask cultures, HW21 (Pta+) and KB100 (Pta-) were grown for 15 generations in glucosecontaining defined medium at 30°C to achieve balanced growth and to eliminate carry-over of undefined nutrients from the inoculum. Growth and acetate accumulation rates were measured over an OD680 range of 0.02 to 0.3 in which growth was exponential and the supply of nutrients (including oxygen) was not limiting. Data from these experiments are shown in Table 3 . The Pta-mutant and nonmutant strains both had very similar specific growth rates of 0.59 to 0.60 h-1. The specific acetate production rate of KB100 in Fig. 1 . The Pta-mutant and nonmutant strains had similar growth kinetics at both temperatures, while specific acetate production in the mutant was lower by a factor of approximately twofold. Specific acetate production rates were lower in fermentors than in flasks for both strains, with the difference being more pronounced in HW21 than in MD050. This may have been due to simple inhibition of the reversible ACK-PTA pathway, caused by the higher levels of acetate in the medium of fermentor cultures of HW21. There was little change in specific acetate production rates in the parent strain before and after mock induction. This was in contrast to the increase of 16-fold in specific acetate productivity that occurs when PTA-competent cells contain a plasmid allowing IL-2 expression (10).
Acetate accumulation in flasks was also measured in an isogenic set of E. coli K-12 strains which included a different pta mutant (TA3514) and a pta-ack double deletion mutant (TA3516). These strains were grown in defined medium plus histidine (100 ,ug/ml to satisfy an auxotrophic requirement) at 37°C for 20 h prior to analyzing the supernatant for acetate. Both the deletion strain and our Pta-strain (MD050) were found to produce lower amounts of acetate compared with their respective nonmutant parents (Table 3) .
Finally, we studied the effect of a mutation in pyruvate oxidase (poxB) on acetate accumulation in our Pta-mutant. A TnS insertion in the pyruvate oxidase gene was transferred into KB100 by P1 transduction. Acetate accumulation and growth rate in this double mutant were measured in glucosecontaining defined medium at 37°C and were found to be indistinguishable from those in its parent.
Effect of the Pta-mutation on IL-2 production. Fig. 2 . While both strains had a similar 2.5-fold increase in OD680 in the first 3 h of induction in flasks, the Pta+ strain stopped growing after a cell density increase of only 1.6-fold in the 20-OD680 fermentor induction and 1.5-fold in the 40-OD680 fermentor induction. In contrast, the Pta-mutant grew substantially more during induction at both cell densities. Specific acetate production during the 5-h induction period was seven-to ninefold less for the mutant than for the wild type at the different cell densities tested.
Specific IL-2 accumulation in the transformed Pta-mutant was 23% lower in fermentor cultures than observed in flask cultures (17 versus 21% in flasks), while in the wild type it was 36% lower than that seen in flask cultures (14 versus 19% in flasks). The data for specific IL-2 accumulation in the PTA-competent strain at the induction cell densities tested in these studies were consistent with our previous observations (10) in which IL-2 expression was less affected by the cell density at induction in the 20-to 40-OD680 range. Figure 2D shows that the Pta-mutant accumulated more total IL-2 in the fermentor as a result of the increase in specific IL-2 accumulation combined with continued growth during induction.
Effect of Pta-mutation on ethanol, lactate, and pyruvate accumulation. In fermentor cultures of the PTA-competent strain HW21(pFC54.t) grown in glucose-containing defined medium, D-lactate and pyruvate were not produced in large amounts. During the 5-h induction period, the concentration of D-lactate increased from approximately 1 to approximately 4 when MDO5OL(pFC54.t) was used. In these fermentor cultures, D-lactate accumulated to 9 mM by the start of induction and subsequently rose to 15 mM at 3 h of induction before falling to 5 mM by the end of the 5-h period. Pyruvate accumulation increased from 1.5 to 8.4 mM during the same period. Ethanol was not produced in amounts greater that 1 mM in either culture before or during induction. Clearly, the lowered amount of acetate produced in the Pta-mutant was not completely compensated for by the slight increases in D-lactate and pyruvate production, particularly when the differences in cell density are taken into account.
DISCUSSION
The data presented here provide evidence that MD050 is a Pta-mutant. At least two groups (3, 9) because acetylphosphate, which is expected to be accumulated by ack mutants, is unstable at physiological pH and temperature and may decompose to acetate. The lack of growth of MD050 on acetate-containing plates and its reduced acetate accumulation implied that it was a Ptamutant rather than an Ack-mutant. The absence of PTA activity in MD050 extracts provided further proof. When transformed for IL-2 production under control of the temperature-sensitive PL promoter, the Pta-mutant continued to grow during induction to a greater extent than its parent. It produced less acetate and greater amounts of IL-2 in terms of both specific and total IL-2 accumulation. These properties made MD050 superior to its parent, MM294-1, as a host organism for expression of IL-2 and possibly other heterologous or homologous protein products.
We believe that MD050 was nearly devoid of PTA activity, despite the fact that it still produced some acetate. Two lines of evidence support this view: first, only trace amounts of PTA activity could be detected in crude extracts; and second, strains carrying a known deletion of PTA continued to produced acetate. However, the precise location and nature of the genetic lesion in MD050 have not been determined by mapping or other more rigorous means, and we cannot completely rule out the possibility that some of the remaining acetate production in MD050 was due to residual PTA activity. Other possible sources of acetate production include the enzyme pyruvate oxidase, which catalyzes the oxidative decarboxylation of pyruvate, and spontaneous hydrolysis of acetyl-CoA. Our results indicate that pyruvate oxidase was not responsible for the remaining acetate produced by MD050.
The 27% improvement in specific IL-2 accumulation achieved in this study by lowering acetate accumulation, using the Pta-mutant, was slightly better than the 17% improvement seen in our previous study, which used medium perfusion to keep acetate concentrations low (10) . If this difference is significant, then it may result from the fact that, in the perfusion cultures, although its concentration was kept below 100 mM, acetate may still have been somewhat inhibitory to maximal IL-2 accumulation. It could also be explained if the blockage in the Pta-mutant used in the present study led to improved utilization of acetyl-CoA through the tricarboxylic acid cycle and oxidative phosphorylation. This may have allowed the formation of more intermediates and ATP for IL-2 synthesis than would be expected from waste acetate formation. Comparisons of the flux rates through the tricarboxylic acid cycle and through oxidative phosphorylation before and after induction of IL-2 synthesis will provide additional information in this regard.
The reason E. coli makes acetate during aerobic growth on glucose is a matter for speculation. It is clear that the bulk of the acetate accumulating in the medium during IL-2 expression came directly from acetyl-CoA via the PTA-ACK pathway (i.e., it appeared not to be made directly from pyruvate). Presuming that pyruvate formate lyase was not active under these conditions, this probably means that pyruvate dehydrogenase is sufficiently active to supply both the tricarboxylic acid cycle (for oxidative phosphorylation and amino acid biosynthetic needs) as well as acetate secretion. Our data show that reducing the acetate formation rate by as much as sevenfold by mutation of pta had no measurable effects on growth rate. We did, however, observe that greater amounts of D-lactate and pyruvate were produced, but not in sufficient amounts to make up the difference in acetate accumulation. Perhaps the production of these acids reflects an imbalance between the cell's glycolytic capacity and its respiratory capacity (7 
